After more than a week of trading down, the Dow Jones
The energy sector received a sliver of good news on the Department of Energy's natural gas report, showing that natural gas-fired generation reached an all-time high, with hopes that increased natural gas utility and manufacturing power generation will remove the massive glut currently in storage, causing prices to rise out of the doldrums.
In the S&P 500, all but two of the industry groups finished the day in the green. Couple this nugget with the poor overall performance and the negative news we've received lately, and I believe that calls for positive reinforcement in the form of a brief recap of the Dow's top performers.
June oil futures ended their seven-day fall as OPEC dismissed the notion that an economic slowdown would curb oil demand in 2012. The Organization of Petroleum Exporting Countries sees an increase in demand for the remainder of the year and decided to increase production by 40,000 barrels a day, totaling the output to 900,000 barrels a day. The cartel's encouraging outlook bolstered oil-producing companies throughout the market, with Kodiak Oil
Pfizer bid its longtime cash-generating drug farewell, as it stopped negotiating new contracts to sell its cholesterol-combating drug Lipitor. With the patent expiring at the end of the year, the company decided to stop promoting the drug, as the generic versions will soon take over the industry.
The property and casualty insurer saw a strong uptick today as debt issues subsided overseas and A.M. Best affirmed the superior rating of A+ for a number of companies' subsidiaries and affiliates.
The oil uptick
The announcement from OPEC could start oil on another run to $100 per barrel. The price has been static around the century mark so far this year, and although this can cost you at the pump, you can still invest in energy and lessen the cognitive dissonance you feel after filling up your tank. You can invest in the volatile oils market, or you could check out our free report, which highlights three companies set to soar when oil prices rise above the $100 market. Find out more about these excellent companies now.
Joel South owns shares of no company listed above. Motley Fool newsletter services have recommended buying shares of Chevron and Pfizer. The Motley Fool has a disclosure policy. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
More from The Motley Fool
Does a Strong Start Make 2018 a Sure Winner for Stocks?
Find out whether the so-called "January effect" is real.
Meet the 2018 Dogs of the Dow
Learn the basics of this simple dividend-investing strategy.
The Dow's Worst Day in 2017
Even with big gains, there were some scary times for the average.